skip to Main Content

Radiotherapy Given at High Enough Dose May Provide Survival Benefits for Pancreatic Cancer Patients

Newsfeed image, light gray text on dark gray background
Patients with early stage pancreatic cancer could be given longer to live if they receive radiotherapy at a high enough dose, according to research presented at the ESTRO 36 conference.

Pancreatic cancer already affects around 338,000 people worldwide annually and this figure is increasing. It is notoriously difficult to treat and consequently has one of the lowest survival rates of any type of cancer. Read more . . .

Back To Top